NCT05239988

Observational Study in COVID-19 Patients Treated With Remdesivir

National Retrospective Observational Study in Patients Treated With Remdesivir Suffering From SARS-CoV-2 Hospitalized in Internal Medicine

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 1,004 (actual)
• Sponsor: Fadoi Foundation, Italy · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Taking into account the high number of COVID-19 patients managed in Italian Internal Medicine, Fadoi Foundation (Italian Scientific Society of Internal Medicine) promotes a national retrospective observational study in patients treated with Remdesivir, analyzing the characteristics of patients and their clinical outcome during hospitalization, and thus providing real-life information potentially useful to integrate the evidence produced by studies conducted under experimental conditions and available in the literature.

Detailed description

This is a multicenter observational, retrospective study, which involves the participation of 35 Nationally Representative Internal Medicine Units, for each center data on all patients suffering from SARS-CoV-2 and treated with Remdesivir are expected to be recorded. Each center will have the task of collecting the data of patients hospitalized consecutively proceeding backwards until March 2020. The study is a no-profit scientific project, promoted by The FADOI Foundation, the Scientific Society of Internal Medicine.

Conditions

• Hospitalization

Interventions

Type	Name	Description
OTHER	no experimental intervention	There will not be any experimental intervention. The study will be conducted according with normal clinical practice

Timeline

• Start date: 2021-11-24
• Primary completion: 2022-06-30
• Completion: 2022-06-30
• First posted: 2022-02-15
• Last updated: 2024-02-28

Locations

30 sites across 1 country: Italy